Med Opportunity Partners is a private equity firm with unique characteristics that specializes in the healthcare industry. We assume superior returns to investors because of our discipline and focus.
Integrity, partnership and creative imagination will always be the relevant differentiation in our portfolio investments. We seize the opportunities. Med Opportunity Partners.
Reliable
Biopharmaceutical Corporation ("RBC") today announced that David
Feldker will join RBC and become its CEO and President effective October
23, 2010, and join RBC's Board of Directors. David was previously Vice President SAFC at
Sigma-Aldrich Corp. with responsibility for the Active Pharmaceutical
Ingredient ("API") contract development and manufacturing segment.